Medical Dosimetry
Volume 34, Issue 1 , Pages 57-62 , Spring 2009

Stereotactic Radiotherapy for Unilateral Orbital Lymphoma and Orbital Pseudo-Tumors: A Planning Study

  • Kazumi Chino, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Arizona Health Sciences Center, Tucson, AZ
    • Corresponding Author InformationReprint requests to: Kazumi Chino, M.D., University of Arizona Health Sciences Center, Department of Radiation Oncology, Tucson, AZ 85724
    • ,
  • James A. Tanyi, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Arizona Health Sciences Center, Tucson, AZ
    • Department of Radiation Medicine, Oregon Health and Science University, Portland, OR
    • ,
  • Baldassarre Stea, M.D., Ph.D.

      Affiliations

    • Department of Radiation Medicine, Oregon Health and Science University, Portland, OR

Received 20 July 2007 ,Accepted 27 December 2007.

References 

  1. Austin-Seymour MM, Donaldson SS, Egbert PR, et al. Radiotherapy of lymphoid diseases of the orbit. Int .J. Radiat. Oncol. Biol. Phys. 1985;11:371–379
  2. Perez CA, Brady LW, Halperin EC, et al. Principles and Practice of Radiation Oncology. 4th ed.. Philadelphia: Lippincott Williams and Wilkins; 2004;pp. 884–7; 2333–4
  3. Bahn HJ, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N. Engl. J. Med. 1993;329:1468–1475
  4. Beckendorf V, Maalouf T, George JL, et al. Place of radiotherapy in the treatment of Graves' orbitopathy. Int. J. Radiat. Oncol. Biol. Phys. 1999;43:805–815
  5. Verellen D, Soete G, Linthout N, et al. Improved target localization and patient set-up by combining real-time infrared tracking and stereoscopic x-ray imaging. Radiother. Oncol. 2003;67:129–141
  6. Jin J, Ryu S, Faber K, et al. 2D/3D Image fusion for accurate target localization and evaluation of a mask based stereotactic system in fractionated stereotactic radiotherapy of cranial lesions. Med. Phys. 2006;33:4557–4566
  7. Petric M, Clark BG, Robar JL. A comparison of two commercial treatment-planning systems to IMRT. J. Appl. Clin. Med. Phys. 2005;6:63–80
  8. Zhou P, Ng AK, Silver B, et al. Radiation therapy for orbital lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 2005;63:866–871
  9. Jereb B, Lee H, Jakobiec FA, et al. Radiation therapy of conjunctival and orbital lymphoid tumors. Int. J. Radiat. Oncol. Biol. Phys. 1984;10:1013–1019
  10. Bartalena L, Pinchera A, Marcocci C. Management of Graves' pphthalmopathy: Reality and perspectives. Endocr. Rev. 2000;21:168–199
  11. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed.. New York: Springer-Verlag; 2002;
  12. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1991;21:109–122
  13. Christenson, J.; Korreman, S. Phantom dose measurements for the ExacTrac X-ray 6D positioning system. Poster presented at the European Society for Therapeutic Radiology and Oncology, October 8-12, 2006 Leipzig, Germany, 2007.
  14. Alonso-Arrizabalaga S, González LB, Ferrando JR. Prostate planning treatment volume margin calculation based on the ExacTrac X-Ray 6D image-guided system: margins for various clinical implementations. Int. J. Radiat. Oncol. Biol. Phys. 2007;69:936–943

PII: S0958-3947(08)00032-0

doi: 10.1016/j.meddos.2007.12.004

Medical Dosimetry
Volume 34, Issue 1 , Pages 57-62 , Spring 2009

Article Tools

* Image Usage & Resolution